Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,627 signal articles · 49 in last 24h · 155,662 total before filter · latest 1h ago
49last 24h
846last 7d
141● bullish (7d)
89● bearish (7d)
214publishers
AllMacro196Earnings105M&A122Regulatory20Product21Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Deere Q3 Preview: Is Tractor Maker an AI Data Center Play? Earnings Report Could Tell Investors 'Yes'
Benzinga38d agoneutral
Deere Q3 Preview: Is Tractor Maker an AI Data Center Play? Earnings Report Could Tell Investors 'Yes'

Farming equipment manufacturer Deere & Company (NYSE:DE) could provide more clues about how the farming sector is doing for investors when the company reports third-quarter financial results Thursday before market open. Here are the earnings estimates, analyst ratings and key items to watch. • Deere stock is holding steady today. What should traders watch with DE? Deere Q3 Earnings Estimates Analysts expect Deere & Company to report third-quarter revenue of $10.73 billion, down from $12.02 billi

Goldman's McClure Says IPO Market 'Wide Open' for Business
Bloomberg38d agoneutralVIDEO
Goldman's McClure Says IPO Market 'Wide Open' for Business

Matthew McClure, Goldman Sachs global co-head of investment, says the IPO market is "open for business," with AI-related companies accounting for more than half of capital raised despite representing about 20% of IPOs this year. Speaking with Dani Burger on "Bloomberg Deals," McClure says confidence is growing in private equity, with $1.5 trillion of capital waiting to be deployed.

TJX Companies Q2 Earnings Call Highlights
MarketBeat38d agoneutral
TJX Companies Q2 Earnings Call Highlights

TJX Companies (NYSE:TJX) reported second-quarter fiscal 2027 results that exceeded its internal plan, supported by strong comparable-store sales at HomeGoods, TJX Canada and TJX International. The off-price retailer raised its full-year outlook for adjusted pre-tax profit margin and adjusted earning

Moderna and Merck Revive mRNA Hopes With Melanoma Success
Bloomberg38d agoneutralVIDEO
Moderna and Merck Revive mRNA Hopes With Melanoma Success

A personalized vaccine developed by Moderna Inc. and Merck & Co. reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Bloomberg's Sam Fazeli joins to discuss.

Ex-Meta Staffer Testifies Daughter, 14, Was Prey on Instagram
Bloomberg38d agoneutral
Ex-Meta Staffer Testifies Daughter, 14, Was Prey on Instagram

Arturo Béjar spent six years working on child safety tools at Meta Platforms Inc., but told a jury he did not fully understand the threats posed to young users on the platform until his 14-year-old daughter signed up for an Instagram account.

Harvard Fund Discloses $2.2 Billion Stake in Musk's SpaceX
Bloomberg38d agoneutralVIDEO
Harvard Fund Discloses $2.2 Billion Stake in Musk's SpaceX

Harvard Management Co. disclosed a $2.2 billion stake in SpaceX, showing how the university's endowment has profited from an early bet on Elon Musk's giant rocket company. Janet Lorin, Bloomberg News Higher Education Reporter, discusses the disclosure and what it signals for other university investments.

Analog Devices Q3 Earnings Call Highlights
MarketBeat38d agoneutral
Analog Devices Q3 Earnings Call Highlights

Analog Devices (NASDAQ:ADI) reported fiscal third-quarter results that exceeded its outlook, with record revenue of $4.02 billion as growth accelerated across its industrial, automotive, communications and consumer markets. CEO and Chair Vincent Roche said the company’s first $4 billion quarter was

⚡Flash Heard: Why Healthcare Is Partying Like It’s Late 2020
The Wall Street Journal38d agoneutral
⚡Flash Heard: Why Healthcare Is Partying Like It’s Late 2020

Moderna and Merck are surging today after the two companies said their experimental mRNA-based treatment succeeded in a late-stage study of high-risk melanoma patients. The SPDR S&P Biotech ETF (XBI) jumped nearly 5%, while the NYSE Arca Pharmaceutical Index climbed over 3%. A positive clinical-trial result typically moves the companies developing the drug—and perhaps their closest competitors—not the entire healthcare sector.

Lowe's earnings: CEO cites caution around consumer spending pressures
Yahoo Finance Video38d agoneutralVIDEO
Lowe's earnings: CEO cites caution around consumer spending pressures

Home improvement retailer Lowe's (LOW) released mixed second quarter results. Yahoo Finance Senior Reporter Brooke DiPalma comes on Market Catalysts to break down the areas where Lowe's is still seeing pressure on consumer spending and CEO Marvin Ellison's latest comments on the company's tariff refund.

Lowe's (LOW) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks38d agoneutral
Lowe's (LOW) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Lowe's (LOW) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.